TMO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TMO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Thermo Fisher Scientific's enterprise value is $239,002 Mil. Thermo Fisher Scientific's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $11,504 Mil. Therefore, Thermo Fisher Scientific's EV-to-EBITDA for today is 20.78.
The historical rank and industry rank for Thermo Fisher Scientific's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of Thermo Fisher Scientific was 27.47. The lowest was 14.97. And the median was 19.87.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-10-31), Thermo Fisher Scientific's stock price is $546.32. Thermo Fisher Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $15.950. Therefore, Thermo Fisher Scientific's PE Ratio (TTM) for today is 34.25.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The historical data trend for Thermo Fisher Scientific's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
EV-to-EBITDA | Get a 7-Day Free Trial | 20.63 | 19.41 | 24.54 | 20.20 | 20.96 |
Thermo Fisher Scientific Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
EV-to-EBITDA | Get a 7-Day Free Trial | 20.43 | 20.96 | 22.06 | 20.44 | 23.04 |
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's EV-to-EBITDA falls into.
Thermo Fisher Scientific's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 239002.399 | / | 11504 | |
= | 20.78 |
Thermo Fisher Scientific's current Enterprise Value is $239,002 Mil.
Thermo Fisher Scientific's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11,504 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (NYSE:TMO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Thermo Fisher Scientific's PE Ratio (TTM) for today is calculated as:
PE Ratio (TTM) | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 546.32 | / | 15.950 | |
= | 34.25 |
Thermo Fisher Scientific's share price for today is $546.32.
Thermo Fisher Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.950.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Thermo Fisher Scientific's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Marc N Casper | officer: Senior Vice President | C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451 |
Lisa P. Britt | officer: Sr. VP and Chief HR Officer | 168 THIRD AVENUE, WALTHAM MA 02451 |
Joseph R. Holmes | officer: VP & Chief Accounting Officer | 168 THIRD AVENUE, WALTHAM MA 02451 |
Gianluca Pettiti | officer: Executive Vice President | C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD STREET, GUILFORD CT 06437 |
Michael A Boxer | officer: Sr. VP and Gen. Counsel | 168 THIRD AVENUE, WALTHAM MA 02451 |
Michel Lagarde | officer: Senior Vice President | 450 LEXINGTON AVE., 31ST FLOOR, NEW YORK NY 10017 |
Stephen Williamson | officer: Sr. VP and CFO | 81 WYMAN STREET, WALTHAM MA 02451 |
Debora L Spar | director | C/O GOLDMAN, SACHS & CO., 200 WEST STREET, NEW YORK NY 10282 |
Jennifer M Johnson | director | C/O FRANKLIN RESOURCES, INC., ONE FRANKLIN PARKWAY, SAN MATEO CA 94403-1906 |
Jim P Manzi | director | 81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454 |
Ruby R Chandy | director | 630 DUNDEE ROAD, SUITE 400, NORTHBROOK IL 60062 |
Mark P Stevenson | officer: Executive Vice President | 850 LINCOLN CENTRE DRIVE, FOSTER CITY CA 94404 |
R. Alexandra Keith | director | ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202 |
Peter E Hornstra | officer: Chief Accounting Officer | 81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454 |
Syed A. Jafry | officer: Sr. Vice President | 345 E. MAIN STREET, WARSAW IN 46580 |
From GuruFocus
By Business Wire • 08-28-2024
By GuruFocus Research • 08-20-2024
By Business Wire • 06-20-2024
By Business Wire • 07-02-2024
By GuruFocus Research • 07-25-2024
By Business Wire • 07-11-2024
By Business Wire • 07-10-2024
By Business Wire • 05-07-2024
By GuruFocus Research • 06-25-2024
By GuruFocus Research • 05-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.